NCT03507075

Brief Summary

Directly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. The goal of this feasibility study is to determine if using technological advancements to remotely, accurately, and securely monitor alcohol use with a newly developed breathalyzer is an effective treatment that is acceptable to participants. If validated, this treatment approach has the potential to facilitate the dissemination of an effective, evidence-based treatment for alcohol dependence to a broader population whose treatment needs are not currently being adequately met.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Nov 2014

Typical duration for phase_1

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2014

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 5, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 5, 2017

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 7, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 24, 2018

Completed
Last Updated

April 24, 2018

Status Verified

April 1, 2018

Enrollment Period

2.1 years

First QC Date

April 7, 2018

Last Update Submit

April 23, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Percent days abstinent from alcohol during intervention

    Three breathalyzer assessments will be collected per day during the treatment period. This outcome measure will consist of the percent days when all three breathalyzers were on time and negative for alcohol.

    Percent days abstinent is the aggregate measure throughout the 21-day intervention period

  • Treatment acceptability

    Participant ratings of treatment acceptability will be collected during assessment sessions

    Baseline, one day after treatment end, and at a one-month follow-up

Study Arms (2)

Contingent

ACTIVE COMPARATOR

The Contingent group will receive nearly immediate monetary payments over the internet each day they remotely provide negative breathalyzer samples, but will not receive the payments if they provide positive samples or fail to provide samples in a timely manner.

Behavioral: Contingency management: Contingent incentives

Noncontingent

SHAM COMPARATOR

The Noncontingent group will receive payments each day they successfully provide samples independent of the alcohol content of those samples.

Behavioral: Contingency management: Noncontingent incentives

Interventions

Monetary incentives are delivered to participants contingent upon on-time breathalyzer submissions and verified abstinence from alcohol.

Contingent

Monetary incentives are delivered to participants contingent upon on-time breathalyzer submissions only with no contingency on alcohol use.

Noncontingent

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years old
  • Provide written informed consent
  • Meet Diagnostic and Statistical Manual criteria for alcohol use disorder
  • Express a desire to cut down or quit drinking

You may not qualify if:

  • Pregnant or lactating
  • Meet Diagnostic and Statistical Manual criteria for other substance use disorder (except caffeine or nicotine)
  • Score 23 or greater on the Alcohol Withdrawal Symptom Checklist
  • Have immediate plans to move out of the area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Alcoholism

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

April 7, 2018

First Posted

April 24, 2018

Study Start

November 15, 2014

Primary Completion

January 5, 2017

Study Completion

January 5, 2017

Last Updated

April 24, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will share

Final research data for this project will be made as available as possible, while safeguarding the privacy of participants and protecting all confidential and proprietary data. Data will be available for use after the main findings from the final dataset have been accepted for publication. The data and associated documentation will only be made available to users under a Data Use Agreement that provides for 1) a commitment to using the data only for research purposes and not to identify any individual participant and 2) a commitment to destroying or returning the data after analyses are completed. To ensure compliance with HIPAA regulations, only a Limited Data Set will be available for use. The method of data release will be determined on a case-by-case basis depending upon the amount and type of data required.

Shared Documents
STUDY PROTOCOL, SAP, ICF